About Peng Khaw
Form D filings for Radiance Therapeutics from 2019 to 2023 list Peng Khaw as director.
Peng Khaw first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Peng Khaw in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Peng Khaw works with at each company, as listed on that company's latest Form D.
Radiance Therapeutics, Inc. · Form D/A, Jun 29, 2023
MS
Marc Sandroff
Director
GS
G. Todd Silva
Executive officer
KA
Ken Abrahams
Director
LM
Laurence Marsteller
Chief Executive Officer and director